Aroldis Chapman’s minor-league rehab assignment wasn’t exactly smooth sailing, but after a maximum 30-day stint recovering from shoulder inflammation (and control problems) the Reds have activated him from the disabled list.
Chapman allowed 12 runs in 13 innings between Double-A and Triple-A, but did post a strong 20/8 K/BB ratio and threw a scoreless inning in each of his final two appearances.
Prior to landing on the DL in mid-May he had a 6.92 ERA and more walks (20) than strikeouts (15) in 13 innings for the Reds, walking 12 of the last 19 batters he faced before the Reds mercifully shut him down. Presumably he’ll be eased back into the bullpen mix with some low-leverage outings, because he may not be out of the woods yet.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.